300199 翰宇药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-4.749-50.642-25.9551.912-31.530
总资产报酬率 ROA (%)-1.089-14.920-9.8580.777-13.938
投入资产回报率 ROIC (%)-1.264-17.110-11.2470.873-17.055

边际利润分析
销售毛利率 (%)59.56949.30677.33672.04280.478
营业利润率 (%)-6.990-117.646-52.6475.313-79.581
息税前利润/营业总收入 (%)15.839-89.442-37.66917.970-73.278
净利润/营业总收入 (%)-9.549-119.486-52.8953.864-84.423

收益指标分析
经营活动净收益/利润总额(%)305.69589.42659.104-701.26029.018
价值变动净收益/利润总额(%)1.919-6.79024.0781,105.394-1.447
营业外收支净额/利润总额(%)4.9490.7040.539-16.0962.360

偿债能力分析
流动比率 (X)0.4260.4800.7081.5530.954
速动比率 (X)0.2320.3730.5421.3420.784
资产负债率 (%)76.56876.10164.08657.81358.264
带息债务/全部投入资本 (%)68.13668.75155.19549.725--
股东权益/带息债务 (%)39.05538.71772.94492.82686.754
股东权益/负债合计 (%)29.62030.42554.90470.16769.909
利息保障倍数 (X)0.683-3.080-2.4681.342-8.907

营运能力分析
应收账款周转天数 (天)86.792189.181148.743143.0630.000
存货周转天数 (天)358.430281.953391.397300.8400.000